print logo

From disease mechanisms to clinical practice

Our overall goal is translating basic medical research into clinical practice. We focus on the disease mechanisms where Norway has clear strengths and together with our partner institutions, cooperations, and strong research teams, we have the research and clinical resources to achieve excellence in translational molecular medicine.

Read more about NCMM...




Nov 6, 2014 10:00 AM - Nov 7, 2014 03:00 PM, Son Add to calendar
Nov 17, 2014 09:00 AM - Nov 28, 2014 03:00 PM, Oslo Science Park Add to calendar
Nov 25, 2014 02:00 PM - 03:45 PM, Forum (Ground floor, Oslo Science Park) Add to calendar


  • NCMM stand at Cutting Edge 2014

    The Oslo Innovation Week where over 40 different events took place all over Oslo, was organized on 13-17 October. One of the events was Cutting Edge 2014 that took place at the Oslo Science Park on 16 October. Cutting Edge aims to highlight new technology and research important for the future. NCMM and the GliaLab had a stand at this event that attracted many visitors.

  • Camila Esguerra new group leader at the Biotechnology Centre of Oslo

    Dr. Camila Esguerra has been recruited as a new group leader to the Biotechnology Centre of Oslo and will start in December. The focus of her research program (Chemical Neuroscience) will be Chemical Biology and disease modeling of neurological disorders (focused currently on epilepsy), using zebrafish as the main model organism.

  • Aspirin reduces cancer risk: interview with Kjetil Taskén in the Norwegian financial magazine Kapital

    Professor Kjetil Taskén has been interviewed by the leading Norwegian financial magazine Kapital. In the September issue of the magazine, Taskén is talking about aspirin effects on cancer and about a new study that will start this fall.

Internal pages